Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New signaling pathway inhibitors developed in Sweden

Feb. 23, 2012

Merck KGaA patents new P70S6K inhibitors

Feb. 23, 2012

New site added to phase II trial of Telcyta

Feb. 22, 2012

Nippon Kayaku anticancer drugs approved for additional indications in Japan

Feb. 22, 2012

PCI Biotech begins treatment in Amphinex study

Feb. 22, 2012

Full BOLERO-2 study results published

Feb. 22, 2012

FDA places clinical hold on Capesaris

Feb. 21, 2012

Novel inhibitor of V600-mutant B-raf shows antitumor activity in animal models

Feb. 21, 2012

Threshold Pharmaceuticals' phase IIb study in pancreatic cancer meets primary endpoint

Feb. 21, 2012

Fuso Pharmaceutical synthesizes new agents to treat cancer

Feb. 21, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...